Literature DB >> 18227206

Long-term engraftment of systemically transplanted, gene-modified bone marrow-derived cells in the adult mouse retina.

C Boettcher1, E Ulbricht, D Helmlinger, A F Mack, A Reichenbach, P Wiedemann, H-J Wagner, M W Seeliger, A Bringmann, J Priller.   

Abstract

AIMS: To provide evidence for a novel route of gene administration to normal and diseased retinas, we performed systemic transplantation of genetically engineered bone marrow-derived cells (BMDCs) to wild-type mice and to mutant mice with retinal degeneration.
METHODS: Lethally irradiated recipient mice-C57BL/6 (wild-type), SCA7 (spinocerebellar ataxia type 7) and FVB/N (rd1 mutant)-were transplanted intravenously with 5x106 BMDCs, which were transduced with a retroviral vector to express the enhanced green fluorescent protein (GFP). Chimeras were killed at 1, 3, 8, 11, 12 and 15 months (wild-type) or at 8 and 12 months (mutants) after transplantation. Eyes were enucleated, and the retinas were analysed using immunohistochemistry.
RESULTS: In wild-type retinas, BMDCs preferentially engrafted in the inner and outer plexiform layers, the ganglion cell layer and the optic nerve. No BMDCs were found in the photoreceptor layer. BMDCs were more common in the degenerating retinas of the mutant mice. The majority of BMDCs in the retina were identified as microglia based on morphology and immunophenotype. Approximately 8-16% of all CD11b(+) cells in the retina expressed GFP. None of the BMDCs expressed neuronal cell markers. GFP-expressing BMDCs were found to persist for more than 1 year after transplantation.
CONCLUSIONS: We demonstrate that gene-modified BMDCs show long-term engraftment and stable expression of GFP from a retrovirus in both wild-type and mutant mouse retinas. Thus, BMDCs may be used as vehicles for gene delivery to the retina.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227206     DOI: 10.1136/bjo.2007.126318

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

Review 1.  Origin of microglia: current concepts and past controversies.

Authors:  Florent Ginhoux; Marco Prinz
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-07-01       Impact factor: 10.005

2.  Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation.

Authors:  Yue Yang; Nikolas L Jorstad; Christine Shiao; Makenzie K Cherne; Shawn B Khademi; Kathleen S Montine; Thomas J Montine; C Dirk Keene
Journal:  Exp Mol Pathol       Date:  2013-04-06       Impact factor: 3.362

3.  Mapping the origin and fate of myeloid cells in distinct compartments of the eye by single-cell profiling.

Authors:  Peter Wieghofer; Nora Hagemeyer; Roman Sankowski; Anja Schlecht; Ori Staszewski; Lukas Amann; Markus Gruber; Jana Koch; Annika Hausmann; Peipei Zhang; Stefaniya Boneva; Takahiro Masuda; Ingo Hilgendorf; Tobias Goldmann; Chotima Böttcher; Josef Priller; Fabio Mv Rossi; Clemens Lange; Marco Prinz
Journal:  EMBO J       Date:  2021-02-08       Impact factor: 11.598

4.  Suppressed retinal degeneration in aged wild type and APPswe/PS1ΔE9 mice by bone marrow transplantation.

Authors:  Yue Yang; Christine Shiao; Jake Frederick Hemingway; Nikolas L Jorstad; Bryan Richard Shalloway; Rubens Chang; C Dirk Keene
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

5.  Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy.

Authors:  Harshini Chakravarthy; Eleni Beli; Svetlana Navitskaya; Sandra O'Reilly; Qi Wang; Nermin Kady; Chao Huang; Maria B Grant; Julia V Busik
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

6.  Characterizing temporal and spatial recruitment of systemically administered RPE65-programmed bone marrow-derived cells to the retina in a mouse model of age-related macular degeneration.

Authors:  Carolina Francelin; Juliana Godoy; Xiaoping Qi; Juliete A F Silva; Maria B Grant; Michael E Boulton
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-06       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.